Related Experiment Videos
DNA triple-helix formation at pyrimidine-purine inversion sites
S P Parel1, J Marfurt, C J Leumann
1Department of Chemistry and Biochemistry, University of Bern, CH-3012 Bern, Switzerland.
Nucleosides, Nucleotides & Nucleic Acids
|September 21, 2001
Summary
Researchers explored triplex forming oligonucleotides (TFOs) for DNA binding. They found that alpha N9-aminopurine nucleosides enable T-A recognition in antiparallel triple-helical DNA structures.
Area of Science:
- Molecular Biology
- Biochemistry
- Nucleic Acid Chemistry
Background:
- Triplex forming oligonucleotides (TFOs) are crucial for targeting specific DNA sequences.
- Understanding TFOs' binding capabilities, especially at inversion sites, is vital for applications like gene regulation and diagnostics.
- Previous studies have explored various nucleoside modifications to enhance TFO binding specificity.
Purpose of the Study:
- To systematically investigate TFOs with modified nucleosides (thymidine, hypoxanthine, aminopurine) for binding to T-A inversion sites in DNA.
- To determine the optimal nucleoside for achieving specific T-A recognition within an antiparallel triple-helical motif.
Main Methods:
- Synthesis of a series of TFOs incorporating alpha- and beta-thymidine, alpha- and beta-N7-hypoxanthine, and alpha- and beta-N7/N9 aminopurine nucleosides.
- Gel mobility assays were employed to assess the binding affinity and specificity of these TFOs to DNA target sequences containing T-A inversion sites.
Main Results:
- The study systematically evaluated the binding of modified TFOs to DNA targets with T-A inversion sites.
- Gel mobility assays demonstrated that T-A recognition within the antiparallel triple-helical motif is achievable.
- Specifically, the use of alpha N9-aminopurine nucleosides opposite the T-A inversion site in the TFO was found to be effective for recognition.
Conclusions:
- Modified nucleosides, particularly alpha N9-aminopurine, can confer specific T-A recognition in TFOs binding to DNA inversion sites.
- This finding advances the design of TFOs for targeted DNA interactions, with potential implications in molecular biology and therapeutic applications.